SINAI HOSPITAL OF BALTIMORE INC.
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $7.7M
- Transactions
- 722
- Companies
- 40
- Average per transaction
- $10,715
Who reported the payments
| Smith+Nephew | $920,507 |
| American Regent | $734,612 |
| Orthofix Medical, Inc. | $563,166 |
| Stryker | $530,656 |
| Eli Lilly | $494,126 |
| Medical Device Business Services, Inc. | $480,781 |
| Haemonetics Corporation | $451,446 |
| Globus Medical | $306,410 |
| Orthopediatrics Corp. | $269,575 |
| UOC USA Inc | $241,450 |
| Microport Orthopedics Inc | $237,725 |
| Jazz Pharmaceuticals Inc. | $226,302 |
| Janssen Research & Development, LLC | $194,031 |
| Novartis | $189,206 |
| Genentech, Inc. | $188,883 |
| SPR Therapeutics, Inc | $132,617 |
| Zimmer Biomet | $109,594 |
| Merck | $103,023 |
| Sage Therapeutics, LLC | $86,000 |
| Amgen | $85,500 |
| KCI USA, Inc. | $81,164 |
| Accriva Diagnostics Inc. | $80,194 |
| Bone Support Inc. | $79,580 |
| E.r. Squibb & Sons, L.L.C. | $66,019 |
| UCB SA | $63,860 |
| Motive Health, Inc. | $63,532 |
| Prenosis Inc. | $62,870 |
| Solventum Corporation | $62,230 |
| Paragon 28, Inc. | $54,900 |
| Providence Medical Technology, Inc. | $43,582 |
| Gilead | $42,178 |
| GSK | $42,037 |
| AbbVie | $36,031 |
| Immunogen, Inc. | $35,145 |
| Arthrex | $30,000 |
| Bristol Myers Squibb | $29,825 |
| TG Therapeutics, Inc. | $26,538 |
| Pfizer | $25,803 |
| Immedica Pharma US, Inc. | $24,997 |
| AstraZeneca | $20,771 |